Medigene AG

MDGEF · OTC
Analyze with AI
6/30/2024
12/31/2023
6/30/2023
12/31/2022
Operating Activities
Net Income-$7-$9-$7-$22
Dep. & Amort.$1$1$1$21
Deferred Tax$0-$0-$1-$44
Stock-Based Comp.$0$0$0$0
Change in WC$1$1-$1-$3
Other Non-Cash-$2$0-$0-$2
Operating Cash Flow-$7-$7-$8-$5
Investing Activities
PP&E Inv.-$0-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$3$0
Other Inv. Act.$8$0$3-$0
Investing Cash Flow$8-$0$3-$1
Financing Activities
Debt Repay.-$1$0-$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$6-$1$0-$0
Financing Cash Flow$5-$1-$0-$0
Forex Effect$0-$0-$0-$0
Net Chg. in Cash$14-$8-$6-$6
Supplemental Information
Beg. Cash$0$17$22$28
End Cash$14$9$17$22
Free Cash Flow-$7-$7-$8-$6